Lifeward VP of Strategy and Market Access Jeannine Lynch to depart May 3

Lifeward disclosed that Jeannine Lynch, who has served as Vice President of Strategy and Market Access since July 2021, will depart the company on May 3, 2026. The company classified this as a termination without cause, meaning Lynch will receive severance and benefits according to her original employment agreement rather than leaving for performance issues or misconduct. For retail investors, this represents a mid-level executive departure in a strategic role focused on market access—important for a medical device company navigating reimbursement and commercialization.

The "without cause" designation suggests an organizational decision rather than performance problems, but the company has not disclosed whether a replacement is lined up or how responsibilities will be redistributed. Watch for any follow-on disclosures about organizational restructuring or new hires in strategy roles, particularly if Lifeward is shifting its go-to-market approach or reimbursement strategy.